ACG Capsules Introduces New Line of HPMC Capsules
The ACGcaps H+ capsules work to meet pharmaceutical and nutraceutical needs while remaining gelatin-free.
ACG Capsules introduced the ACGcaps H+ capsule for pharmaceutical and nutraceutical needs on Aug. 19, 2019. The new line of hydroxypropyl methyl cellulose (HPMC) capsules are pH-independent, non-ionic, work without a gelling agent, and are suitable for hygroscopic and moisture-sensitive formulations.
The capsules comply with the requirements of dissolution performances across all biological pH ranges while working to reduce cross-linking problems, which occur with gelatin-based capsules and cause a limited dissolution performance.ACGcaps H+ capsules can also be used for filling granules, powders, pellets for prescription and non-prescription pharmaceutical ingredients, nutraceutical dietary supplements, and traditional medicines.
“The new and enhanced range of HPMC capsules is designed to give pharma and nutraceutical customers added peace of mind by providing product protection and desired formulation release. The new line contains no gelatin, wheat, gluten, animal by-products, or starch, making it ideal for supporting clean label claims and vegetarian diets,”said Selwyn Noronha, CEO for ACG Capsules, in a company press release.
Source: ACG Capsules
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
